Evaluation of the elevation of host cell biosynthesis of deoxynucleoside triphosphates (dNTP's) induced by human cytomegalovirus (HCMV) infection as a target for antiviral therapeutics was carried out. The concentrations of all four intracellular dNTP'~rose rapidly following HCMV infection, and were markedly above baseline by 8 h post infection (p.l.), All four deoxynucleoside triphosphates remained elevated above baseline for at least 72 h p.l,
Introduction
Viruses subjugate the metabolic machinery of the host cell for their replication cycle. A critical metabolic problem for large DNA viruses is the availability of deoxynucleoside triphosphate (dNTP) precursors, since the levels of deoxyribonucleoside triphosphates are normally tightly controlled in the uninfected host cell. As part of this control, appreciable levels of dNTP are present only during the S phase of DNA synthesis (Bray and Brent, 1971 ; McCormick et al., 1983; Schobitz et al., 1991) . Further constraints on the biosynthesis of dNTP's are that the host enzymes involved [e.g. cytoplasmic thymidine kinase (Gentry, 1992) ; ribonucleotide reductase (Reichard, 1987) ] are present only during active host replication of the genome, and that the concentrations of all four deoxyribonucleotide pools regulate the activity of these biosynthetic enzymes through allosteric and end-product inhibition (Hards and Wright, 1984; Wright et et., 1990). Large DNA viruses utilize different strategies to obtain sufficient DNA precursors for replication. For example, although herpes simplex virus (HSV) and human cytomegalovirus (HCMV) have a high degree of DNA homology (Chee et aI., 1990) , they utilize quite different strategies for obtaining DNA precursors. HSV utilizes both de-novo biosynthesis and the salvage pathways through virally encoded enzymes (ribonucleotide reductase for the de-novo and deoxynucleoside or 'thymidine' kinase for the salvage pathways) (Nutter et aI., 1985) . HCMV has adapted by activating the host cell to produce deoxynucleotide precursors. Host cell functions induced by HCMV infection to elevate the amounts of intracellular dNTP (Biron et al., 1986) include thymidine kinase (Estes and Huang 19J7) , other nucleoside kinases (Lewis et aI., 1984; Watkins and St. Jeor, 1984) , and dihydrofolate reductase (Wade et aI., 1992) . This increase in intracellular dNTP's after HCMV infection has not been closely studied; however, it is known that it is not under the same regulation as the normal cell cycle and, consequently, it is a potential target for new antiviral therapy. Therefore, to examine this possibility, the time course of elevation of intracellular deoxynucleoside triphosphates after HCMV infection was followed, and the effect of a variety of potential antiviral agents at a time of active dNTP synthesis tested. It was found that inhibitors of the de-novo biosynthesis of deoxynucleoside triphosphates also inhibited cytomegalovirus DNA replication at concentrations that were not overtly toxic to the host cell. Inhibition of de-novo host cell deoxynucleoside triphosphate biosynthesis also had a greater effect on HCMV than on HSV DNA replication.
Results

Time course of elevation of dNTP after HCMV infection
Firstly the levels of intracellular deoxynucleoside triphosphates (dNTP) at various times after HCMV infection of a human lung fibroblast line were examined. The levels of intracellular dNTP rose rapidly after HCMV infection, with levels of all four increasing markedly above baseline by 8 hr post infection (p.i.) (the first time point examined; Fig. 1 ). At 8 h p.i., however, the levels of each dNTP differed, from 4.3 pmol 10--6 cells for dITP to 100 pmol 10--6 cells for dATP. The relative changes from the pre-infection levels at 8 h p.i., however, were quite similar for each deoxynucleotide pool (about 6-fold, Fig. 1 ). The levels of all four deoxynucleoside triphosphates remained elevated above pre-infection levels for the 72 h time period examined (Fig. 1) . The demonstration of an increase in dNTP after HCMV infection, with the greatest change from baseline occurring in dITP, confirms previous studies (Biron et al., 1986) .
Effect of pyrimidine biosynthesis inhibitors on HCMV DNA synthesis
Next it was determined whether this elevation in dNTP levels seen after HCMV infection was necessary for viral DNA synthesis. Therefore, a series of drugs with known inhibitory effects upon the de-novo pathway of pyrimidine biosynthesis (see Fig. 2 ) were chosen. Confluent human fibroblasts infected with HCMV or HSV at MOI=3 were treated with different concentrations of the various drugs, and viral DNA was quantified by DNA dot blots at 72 h p.i. infection for HCMV and at 24 h p.i. for HSV. All drugs inhibited DNA replication of cytomegalovirus (Table 1) at concentrations well below those producing host cell toxicity as measured by the MIT assay. A representative set of curves is provided for the drug 6,diazo-5-oxo-1-norleucine (DON) (Fig. 3) . None of the drugs tested produced a 50% decrease in the MIT assay relative to untreated cells in the concentration ranges examined. The TD so could be extrapolated for several drugs (acivicin-ACN, azaserine-AlS, phosphoracetyl-L-aspartic acid-PALA, and pyrazofurin-PYRA and ganciclovir; see Table 1 ). For the other drugs tested, a TD so was not reached and could not be extrapolated with any certainty. In such cases, the highest concentration of these drugs tested for cell toxicity is listed in Table 1 .
For all inhibitors of de-novo pyrimidine biosynthesis examined, the drug concentration necessary to inhibit DNA synthesis by 50% (ED so ) for HCMV DNA synthesis was at least 10-fold lower concentration than the ED so for inhibition of HSV DNA synthesis. For four drugs (DL, BREQ, DON, and PALA) it was unclear whether the drug concentration necessary to inhibit HSV DNA synthesis by 50% (ED so ) would be reached before the drug was toxic to the cells -the ED so for HSV could not be extrapolated. For BREQ and DON, the ED so for HCMV was at least 10fold lower than for HSV; for PALA and DL, this may repre- (Table 1) . In comparison, the nucleoside analogue ganciclovir inhibited HSV-1 DNA synthesis at lower concentrations than for HCMV DNA synthesis ( Table 1) .
Effect of brequinar on dTTP pools
Brequinar had the highest differential effect on HCMV DNA synthesis compared to host toxicity in vivo (Noe et al., 1990) . For this reason, we compared its effects on dDP pools in HCMV-infected and uninfected cells were compared. HCMV-infected fibroblasts and uninfected control cells were treated with brequinar at a concentration that reduced HCMV DNA levels by 90% (Table 2) . At 72 h p.i., cells were collected and intracellular dTTP levels were assayed. It was found that in HCMV-infected cells, brequinar reduced the dTTP pools of treated cells to 22% of that found in untreated cells. Brequinar did not have a preferential effect on CMV infected cells and reduced the dTTP pool whether or not the cells were HCMV-infected.
In uninfected cells, brequinar reduced dTTP pools of treated cells to 5.3% of that in untreated cells. As in the previous experiment, HCMV infection markedly increased the level of dTTP in cells.
Discussion
Cytomegalovirus differs considerably from herpes simplex by lacking virally encoded enzymes for providing DNA precursors. Cytomegalovirus infection activates the host cell and is known to induce the synthesis of several enzymes of the de-novo synthesis pathway of deoxynucleotides including dihydrofolate reductase (Wade et al., 1992) , as well as other nucleoside kinases of the salvage Orotidine-5'monophosphate 40 0.1 >400 (>4000x) decarboxylase "Ratio of toxic dose for host cells to the ED50 for inhibition of HCMV DNA replication bin instances in which neither a 50% endpoint was observed nor an extrapolation to 50% could be obtained, the highest concentration examined is indicated. elevated from baseline after HCMV infection, with the greatest change from baseline occurring in dTTP pools. This is in agreement with the previous studies of others (Biron et aI., 1986) . It was found that this elevation occurs rapidly and is prolonged (Fig. 1) . A slight dip in levels of dCTP and dGTP at 24 h corresponds with the first peak of viral and host DNA synthetic activity (St. Jeor and Hutt, 1977) . It is possible that the increased production of dNTP observed at 8 h p.i. is partially offset at 24 h by increased utilization of dNTP for DNA synthesis. Even without accounting for the possibility of increased dNTP utilization, however, the levels of all four dNTPs remain elevated (Fig. 1) , implying' that host cell de-novo biosynthesis of DNA precursors is strongly activated by HCMV infection.
The rapidly produced and continuously high levels of dNTP induced by HCMV infection are a potential target for antiviral chemotherapy. It has been demonstrated by the authors and others (Karlsson and Harmenberg, 1988; Hamzeh et al., 1993 ) that inhibitors of ribonucleotide reductase can inhibit production of HCMV in tissue culture. It was found that all inhibitors of the de-novo pathway of pyrimidine biosynthesis tested inhibit HCMV replication (Table 1) .
These drugs are much less effective at inhibiting the DNA synthesis of HSV-1 than that of HCMV (Table 1) even though the de-novo pathway of nucleotide metabolism would be expected to be affected equally by these inhibitors in cells infected with either virus. The most likely explanation for the increased susceptibility of HCMV DNA synthesis to these inhibitors is that whereas dNTP pools are supplied by multiple sources for HSV replication (Nutter et al., 1985) , dNTP pools for HCMV replication must come from de-novo synthesis. In HSV infection, de-novo synthesis is augmented by viral ribonucleotide reductase, the salvage pathway, and the breakdown of the host cell DNA (Nutter et al., 1985) . In contrast, HCMV does not encode biosynthetic enzymes for the augmentation of either the de-novo or salvage pathways. It is therefore not surprising that HCMV DNA synthesis, where DNA precursors are obtained solely from host cell biosynthesis, is more sensitive to drugs that inhibit the pyrimidine de-novo biosynthetic pathways of the host cell.
The host cell tolerated the presence of these drugs well compared to the virus, suggesting the possibility that e -e ACN (HCMV) pathway such as thymidine kinase (Estes and Huang, 1977) and deoxyguanosine kinase (Lewis et al., 1984; Watkins and St. Jeor, 1984) . Cytomegalovirus infection will also raise levels of intracellular deoxynucleotides (Biron et al., 1986) . This activated state occurs very soon after HCMV infection. Induction of host proto-oncogenes has been demonstrated within 2 h p.i. (Boldogh et al., 1991) . Estes and Huang found that cellular thymidine kinase activity was induced by 12 h after HCMV infection (the earliest time point they examined) (Estes and Huang, 1977) . The present study is almost certainly the first investigation of the time course of dNTP elevation after HCMV infection. We found that the dNTP pools are markedly Untreated BREQ Treated Fold-reduction 19-fold 5-fold a Results are in pmol 10 6 cells expressed as mean ± SD these agents could be used as antiviral drugs with a significant therapeutic ratio. Although only cell toxicity rather than inhibition of cell replication was investigated, it was found to have a similarly low toxicity to cells that were actively dividing or were confluent. On the other hand, organ specific toxicities in vivo may show more toxicity than is observed in vitro, as specific organs with high rates of DNA synthesis are exposed to the drugs. Nevertheless, the admittedly sparse clinical data available on these agents from the oncology literature (in which they were invariably disappointing because of their lack of cytotoxicity) indicates that marked toxicity with these agents is unlikely. Clinically tolerated levels of brequinar (peak concentrations of 1 mM) (Noe 1990) , PALA (peaks of 900 IlM) (Grem et al., 1988) , acivicin (0.9Ilg rnr"), and DON (2 mg L-1 average concentration) (Ahluwalia et aI., 1990) are much higher than the observed ED so of each drug for inhibition of cytomegalovirus replication. This implies that these drugs could be clinically useful for serious HCMV infection. There are several possible explanations for this selective effect on HCMV DNA synthesis compared to host toxicity. Firstly, viral infection requires considerably more dNTP precursors than host cell division -HCMV infection increases the overall rate of PNA synthesis (Albrecht et al., 1976; G6ncz61 and Plotkin, 1984) . Decreasing the supply of these precursors interrupts viral DNA synthesis; and, as DNA polymerases must be supplied with all four DNA precursors, the limiting availability of more than one may synergistically decrease the rate of DNA synthesis. Secondly, nucleotide imbalances have been shown to alter the function of host nucleotide metabolic enzymes, especially ribonucleotide reductase -the rate-limiting enzyme for the de-novo pathway (Reichard, 1987) . Thirdly, alterations of dNTP balance have been shown to induce apoptosis (Kizaki et al., 1988) and could interiere with viral replication if the host cell died before viral DNA replication could occur.
In summary, characterization of the elevation of dNTP following HCMV infection of human fibroblasts in vitro was carried out. All inhibitors of the pyrimidine de-novo biosynthetic pathway tested had significant antiviral effect against HCMV replication in vitro. All of these drugs were effective (greater than 90% inhibition of HCMV DNA synthesis compared to untreated controls) at concentrations with minimal toxicity to the uninfected host cell, as measured by the MTI assay. Furthermore, the ED so against the DNA synthesis of HCMV was at least 10 fold lower than that for the inhibition of HSV-1 DNA synthesis (Table  1) . The anti-HCMV activity of brequinar was temporally associated with decreasing intracellular dTIP pools. The viral requirement for dNTP's demonstrates a potential antiviral target that is not virally encoded. The favourable EDsafTD so ratio (Table 2) appears to be the result of the Pyrimidine biosynthesis inhibitors as antivirals 11 relatively large and unregulated use of dNTP by virusinfected cells compared to uninfected cells.
Materials and Experimental Procedures
Cells and virus
Human embryoniclung fibroblastcells (MRC-5)were obtained from the American Type Culture Collection (Beckville, MD, USA). Cells were maintained in 5% CO 2 at 37°C in Eagle's Minimal essential medium (Gibco, Grand Island, NY, USA), supplemented with glutamine (2 mM) (Gibco, Grand Island, NY, USA), and 10% fetal calf serum (complete medium) (Gibco, Grand Island, NY, USA).These cells were used for the propagation of the Towne strain of HCMVand F strain of HSV-1(F) as previouslydescribed (Hamzeh et al., 1990) .
Drugs
Brequinar(BREQ)was suppliedby DupontMerck (Wilmington, DE, USA). Azaserine (AZS), acivicin (ACN), pyrazofurin (PYRA), dichloroallyllawson (DL), 6, diazo-5-oxo-1-norleucine (DON), and phosphoracetyl-L-aspartic acid (PALA) were obtained from the National Cancer Institute. Ganciclovir was supplied by Syntex (Palo Alto, CA, USA).
Viral infection of cell monolayers
Confluent 75 ern" (T75; Corning, NY, USA) were infected at a multiplicity of infection of 3 (3 MOl). Virus was allowed to adsorb for 1 h at 37°C with periodic agitation. At that time unabsorbed virus was removed and complete medium was added until the time indicated in kinetic studies, routinely 72 h post infection (p.i.) for HCMV and 24 h p.i. for HSV infection, unless otherwise indicated. Cell monolayers were washed extensively with phosphate-buffered saline (PBS) and then trypsinized. For DNA hybridization experiments, the cells were washed twice with phosphate-buffered saline, counted, and 10 6 cells were added to individual wells of a dot blot apparatus (Schleicher& Schuell, Inc. New York, USA) . For dNTP extraction, the trypsinized cells were centrifuged at 1000 x g for 10 min, and then extracted with 60% methanolat -20°C. After overnightextraction, the cells were centrifuged at 30 000 x g for 35 min and the supernatantfraction was removed. This extract was then lyophilized with a Sorvall concentrator at 4°C and reconstituted with distilled water immediately before the assay of deoxynucleoside triphosphates.
Dot blot
HCMV DNA replication was measured by dot blot DNA-DNA hybridization with a cloned BamHI-Q fragment from the end of the HCMVgenomeas a probe (Hamzeh et al., 1990) .Total cellular and viral DNA were processed for dot blot DNA-DNA hybridization, as previously described (Hamzeh et al., 1990; Hamzeh et al., 1991) .The BamHI-Q fragmentfrom HCMVwas prepared as described (12) (13) (14) and was a gift from G. Hayward. Briefly,the HCMV-infected monolayers were treated with trypsin at 72 h and the cells were counted. Cells (2 x 10 5 ml") were preparedfor dot blot hybridization without DNA extraction by adding sodium hydroxide to a final concentration of 0.5 M and incubating for 1 hr at 37°C. At the end of the incubation period, the samples were neutralized with an equal volume of 3 M sodium acetate (pH 5.2), and applied to nylon membranes (Biodyn A; Pall Corp., East Hills, NY, USA) under vacuum with a 96-well apparatus (Schleicher & Schuell, Inc.) . The membranes were dried at 80°C for 3 h and then stored in a closed plastic bag. They were then prehybridized for 2 h at 67°C in sealed bags containing 6 x SSC (1 x SSC is 0.15 M NaCI plus 0.015M sodium citrate [pH 7.4]), 5 x Denhardt solution (0.1% Ficoll, 0.1% polyvinyl pyrollidone, 0.1% bovine serum albumin), 0.2% sodium dodecyl sulfate (SDS), and 100 /-lg of salmon sperm DNA perml (all reagents from Sigma, St. Louis, MO, USA). After prehybridization, the membranes were hybridized with 10 9 cpm of a radioactive HCMV DNA probe in a mixture of the same composition as prehybridization buffer, The probe was labeled with 32[P]dCTP by nick translation with a commercial nick translation kit (Bethesda Research Laboratories Bethesda. MA. USA) or by random priming as recommended by the manufacturer of the Oligolabeling Kit (Pharmacia Piscataway, NJ, USA). At the end of the hybridization period, each membrane was washed in at least 250 ml of each of the following solutions: 0.5% SDS-2xSSC for 5 min. 0.1% SDS-2xSSC for 5 min, 0.5% SDS-0.1xSSC at 65°C for 2 hr with gentle agitation, and finally 0.5% SDS-O.5xSSCfor 30 min at 65°C. The membranes were dried at 80°C for 2 h and then exposed to X-ray film (Kodak X-Omat, Eastman Kodak, Rochester, NY, USA). To quantify bound probe, individual dots were cut out and radioactivity was counted using a Beckman LS-233 scintillation spectrometer and Fluorosol scintillation cocktail (National Diagnostics, Atlanta, USA).
Toxicity studies
MRC-5 monolayers were treated with each drug for 72 h in medium with 10% fetal calf serum, after which both cell number and total cellular DNA were determined.
MTTAssay
The MTT assay was used as a measure of an intact mitochondrial respiratory chain (Mossman, 1983) . Cells were plated in microtitre plates for various lengths of time in the presence or absence of drug as outlined above; 15 /-ll of a 5mg ml-1 MTT solution were added and the mixture was incubated for 2 h at 37°C. At that time, lysing buffer (0.1 ml of 10% SDS, 45% dimethylformamide adjusted to pH 4.7 with glacial acetic acid) was added and mixed to dissolve the blue formazan crystals. After 15 min, the absorbance at 570 nm was determined in a Titertek Multiskan microtitre plate reader (Molecular Devices, Menlo Park, CA, USA).
Deoxynucleoside triphosphate assay
A bioassay for dNTP involving incorporation of radioactive dNTP into DNA used the method of Hunting and Henderson (Hunting and Henderson, 1981) . Briefly, the following components are mixed in a total volume of 80 ul: 0.02 A 26D units of PolyA*PolyT or Polyl*PolyC (Pharmacia), 5mM MgCI 2, 10mM Tris, pH 8.3, 0.22 mg mt' bovine serum albumin (BSA) (Sigma, fraction V BSA), 2.5 mM deoxyadenosine monophosphate (Sigma), 50 /-lM 2-mercaptoethanol, 50 pmol of the deoxynucleoside triphosphate complementary to the unknown to be assayed, with 1 /-lCi of tritiated complementary deoxynucleoside triphosphate (ICI). The unknown was serially diluted and 10 ul at the desired dilution were added to the sample; the reaction was started with the addition of 10 ul, containing 1 unit of the klenow fragment of E. coli DNA polymerase (Boeringer Mannheim, Indianapolis, IN, USA). The reaction was allowed to xxproceed to completion (40min for dATP and dTTP, 120 min for dCTP and dGTP). The reaction products were spotted onto Whatman No. 3 filter paper disks (Whatman, Maidstone, UK) and unreacted dNTP was removed by repeated washing with DNA precipitation solution (10% trichloroacetic acid (Sigma) and 1% sodium pyrophosphate (Sigma». The amount of dNTP in the sample was determined by comparison with a standard curve of known concentration for each of the four deoxynucleoside triphosphates run in parallel.
Calculations
The fractional binding of radioactive viral DNA probe in DNA-DNA dot blotting by extracts of cells infected in the presence and absence of drug was calculated with the following formula: 
